series-c-plus
Stage
2
Investors
About
MBX Biosciences is a clinical-stage biotechnology company developing precision peptide therapeutics to treat endocrine and metabolic diseases using a proprietary peptide discovery and development platform (PEPs). The company maintains a pipeline of peptide candidates in various stages of clinical development focused on improving management of endocrine and metabolic disorders.
Explore MBX Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.